{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["14(10)"],"submitter":["Li CR"],"funding":["National Key R&D Program of China","Major Projects in Provincial and National Union Construction of Henan Medical Science Research Plan","National Natural Science Foundation of China","National Key Research & Development Project","National Key Research and Development Program of China","Jiangsu Provincial Key Department of Maternal and Child Health Fund"],"journal":["Clinical and translational medicine"],"pagination":["e70051"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11480968"],"repository":["biostudies-literature"],"pubmed_title":["BIN2 inhibition suppress ovarian cancer progression meanwhile protect ovarian function through downregulating HDAC1 and RPS6 phosphorylation respectively."],"pmcid":["PMC11480968"],"funding_grant_id":["FXK201712","SBGJ202001002","32070840","2021YFA1100300","2021YFC2700602"],"pubmed_authors":["Li YR","Zhang D","Zhang SP","Guan YC","Zhang CL","Tian PZ","Xu JN","Ying XY","Li CR","Zhu FY","Zhang SD","Yang LL","Xie SY","Yao HJ","Yang ZX","Yue F","Wang Q","Wang RL","Cao Y","Wang LL","Cui CC","Yang YJ"],"additional_accession":[]},"is_claimable":false,"name":"BIN2 inhibition suppress ovarian cancer progression meanwhile protect ovarian function through downregulating HDAC1 and RPS6 phosphorylation respectively.","description":null,"dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Oct","modification":"2026-07-15T04:11:22.662Z","creation":"2025-04-04T11:05:21.085Z"},"accession":"S-EPMC11480968","cross_references":{"pubmed":["39412213"],"doi":["10.1002/ctm2.70051"]}}